LUNG FY 2020 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+0.4% YoY

Gross Profit

$21M64.8% margin

Operating Income

-$32M-98.8% margin

Net Income

-$32M-98.5% margin

EPS (Diluted)

$-0.90

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$264M

Total Liabilities

$38M

Stockholders' Equity

$226M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$33M	+0.4%
Gross Profit	$21M	$22M	-5.4%
Operating Income	-$32M	-$18M	-81.3%
Net Income	-$32M	-$21M	-55.7%